GC26739
p38 MAP Kinase Inhibitor Ⅵ
Also known as 2-(5,6-dimethylthieno[2,3-d]pyrimidin-4-yl)sulfanyl-1-(4-fluorophenyl)ethanone
p38 MAP Kinase Inhibitor VI (compound c32) is a p38 MAPK inhibitor with an inhibition rate of 24%
ChemicalCAS421578-46-3MW332.42FormulaC16H13FN2OS2
- CAS number
- 421578-46-3
- Molecular weight
- 332.42
- Formula
- C16H13FN2OS2
- Solubility
- DMSO ： 5 mg/mL (15·04 mM; Need ultrasonic)
- InChIKey
- UGHHFQVLSOSMQA-UHFFFAOYSA-N
- Catalogue number
- GC26739
- Brand
- GLPBIO
Computed properties PubChem CID 696861 · XLogP 4.7 · TPSA 96.4 Ų · H-bond donors 0
- XLogP
- 4.7
- TPSA
- 96.4 Ų
- H-bond donors
- 0
- H-bond acceptors
- 6
- Rotatable bonds
- 4
- Heavy atoms
- 22
SMILES CC1=C(SC2=C1C(=NC=N2)SCC(=O)C3=CC=C(C=C3)F)C
Computed descriptors from PubChem (CID 696861), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il